Tony D. Angell - Concepedia

Author

Tony D. Angell

Also Known As

Tony D. Angell, Tony D.R. Angell

Publications

154

Citations

H-Index

Concepts

All Affiliations

Tony D. Angell is an author at GlaxoSmithKline (United Kingdom) specializing in drug discovery, medicine, and pharmacology.

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	154
2	Pharmacology	3	3	154
3	Biochemistry	2	2	127
4	Natural Sciences	1	1	56
5	Chemical Biology	1	1	56

Tony D. Angell

Publications

154

Citations

H-Index

Page 1

	Year	Citations
Pyrazolopyridines as a novel structural class of potent and selective PDE4 inhibitors J. Hamblin, Tony D. Angell, Stuart P. Ballantine, Bioorganic & Medicinal Chemistry Letters Combinatorial ChemistryNovel Structural ClassBiochemistryMedicineRational Drug Design	2008	71
Biphenyl amide p38 kinase inhibitors 4: DFG-in and DFG-out binding modes Richard Angell, Tony D. Angell, Paul Bamborough, Bioorganic & Medicinal Chemistry Letters Molecular DockingMedicinal ChemistryDfg-out Binding ModesDrug TargetBiochemistry	2008	56
Biphenyl amide p38 kinase inhibitors 2: Optimisation and SAR Richard Angell, Tony D. Angell, Paul Bamborough, Bioorganic & Medicinal Chemistry Letters Kinase Inhibitors 2Medicinal ChemistryMedicineRational Drug DesignPharmacotherapy	2007	27

Page 1